Claire’s, Beauty Plus cosmetic products recalled after testing positive for asbestos

North Carolina
Recall products_1560043099107.jpg_91368721_ver1.0_640_360_1560194519050.jpg.jpg

Two cosmetic products are being recalled after they tested positive for asbestos, according to the Food and Drug Administration. 

On May 29 and 30, Claire’s Stores, Inc., and Beauty Plus Global undertook voluntary recalls of their respective products that tested positive for asbestos during the FDA’s ongoing testing of cosmetics. 

The FDA is advising consumers to not use either of these products:

  • Beauty Plus Global Contour Effects Palette 2, Batch No. S1603002 / PD-C1179
  • Claire’s JoJo Siwa Makeup Set, SKU #888711136337, Batch/Lot No. S180109

On March 5, the FDA issued a similar alert for other Claire’s cosmetic products. 

According to the FDA, samples of the following products tested positive for tremolite asbestos during FDA testing:

  • Claire’s Eye Shadows Batch No/Lot No: 08/17
  • Claire’s Compact Powder Batch No/Lot No: 07/15
  • Claire’s Contour Palette Batch No/Lot No: 04/17

Claire’s responded in a statement to WFLA 

Claire’s Stores, Inc. has voluntarily recalled the JoJo Cosmetic Kit out of an abundance of caution after testing by the U.S. Food and Drug Administration indicated the possible presence of trace amounts of asbestos fibers in the powder eyeshadow element of the kit. Claire’s stands behind the safety of this item and all other Claire’s cosmetic items, as such small trace amounts are considered acceptable under European and Canadian cosmetic safety regulations. In addition, last year Claire’s moved to talc-free cosmetic manufacturing to prevent any further concerns about talc contamination. Claire’s also supports increased FDA oversight of personal care products. 
We will provide a full refund to any customers who purchased the product. 

Asbestos is a naturally occurring mineral that is often found near talc, an ingredient in many cosmetic products and is known to carry the risk of causing cancer, according to the FDA.


Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories